Evidence map›Paper›PMID 25159809›Full record

ArticleAlcoholism, clinical and experimental research2014

Overweight and obesity among children and adolescents with fetal alcohol spectrum disorders.

Anita J Fuglestad, Christopher J Boys, Pi-Nian Chang, Bradley S Miller, Judith K Eckerle, Lindsay Deling, Birgit A Fink, Heather L Hoecker, Marie K Hickey, Jose M Jimenez-Vega and 1 more

Abstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Role of gut microbiota and its functional products in prenatal alcohol-induced anxiety-like behavior.Progress in neuro-psychopharmacology & biological psychiatry · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. A narrative review of highly processed food addiction across the lifespan.Progress in neuro-psychopharmacology & biological psychiatry · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Anita J FuglestadDepartment of Psychiatry, University of Minnesota, Minneapolis, Minnesota.
Christopher J Boys
Pi-Nian Chang
Bradley S Miller
Judith K Eckerle
Lindsay Deling
Birgit A Fink
Heather L Hoecker
Marie K Hickey
Jose M Jimenez-Vega
Jeffrey R Wozniak
University of Minnesota · USCincinnati Children's Hospital Medical Center · USEmory University · US

Funding

LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., KISSELA, BRETT M · 2015 to 2024
$37.5M
Postnatal Choline Supplementation in Children with Prenatal Alcohol ExposureR33AA019580 · NIAAA · UNIVERSITY OF MINNESOTA · PI WOZNIAK, JEFFREY ROBERT · 2011 to 2013
$647k
Postnatal Choline Supplementation in Children with Prenatal Alcohol ExposureR21AA019580 · NIAAA · UNIVERSITY OF MINNESOTA · PI WOZNIAK, JEFFREY ROBERT · 2009 to 2010
$405k
NCATS NIH HHS UL1 TR001425NIAAA NIH HHS 5R21AA019580NIAAA NIH HHS R21 AA019580NIAAA NIH HHS R33 AA019580NIAAA NIH HHS R33AA019580
6 · The paper itself

Abstract

backgroundBecause prenatal alcohol exposure is associated with growth deficiency, little attention has been paid to the potential for overweight and obesity in children with fetal alcohol spectrum disorders (FASD). This study examined the prevalence of overweight/obesity (body mass index [BMI]) in a large clinical sample of children with FASD.

methodsChildren, aged 2 to 19 years, who were evaluated for FASD at University Clinics, included 445 with an FASD diagnosis and 171 with No-FASD diagnosis. Prevalence of overweight/obesity (BMI ≥ 85 percentile) was compared to national and state prevalence. BMI was examined in relation to FASD diagnosis, gender, and age. Dietary intake data were examined for a young subsample (n = 42).

resultsThirty-four percent with any FASD diagnosis were overweight or obese, which did not differ from the No-FASD group or U.S. prevalence. Underweight was prevalent in those with fetal alcohol syndrome (FAS) (17%). However, increased rates of overweight/obesity were seen in those with partial FAS (40%). Among adolescents, those with any FASD diagnosis had increased overweight/obesity (42%), particularly among females (50%). The rate in adolescent females with FASD (50%) was nearly 3 times higher than state prevalence for adolescent females (17 to 18%), p < 0.001. In the young subsample, those who were overweight/obese consumed more calories, protein, and total fat per day than those who were not overweight or obese.

conclusionsRates of overweight/obesity are increased in children with partial FAS. In adolescents, rates are increased for any FASD diagnosis (particularly in females). Results are suggestive of possible metabolic/endocrine disruption in FASD-a hypothesis for which there is evidence from animal models. These data suggest that clinicians may consider prenatal alcohol exposure as a risk factor for metabolic/endocrine disruption, should evaluate diet as a risk in this population, and may need to target interventions to females prior to puberty to effect changes in overweight-related outcomes.

Indexed as

Body Mass IndexAdolescentAlcohol DrinkingChildChild, PreschoolFemaleFetal Alcohol Spectrum DisordersHumansMaleObesityOverweightPregnancyRisk FactorsYoung AdultBody Mass IndexFetal Alcohol Spectrum DisordersNutritionObesity

Identifiers

PMID25159809
PMCPMC4691582
OpenAlexW2106387450

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.